ZA807467B - Chemical compound - Google Patents

Chemical compound

Info

Publication number
ZA807467B
ZA807467B ZA00807467A ZA807467A ZA807467B ZA 807467 B ZA807467 B ZA 807467B ZA 00807467 A ZA00807467 A ZA 00807467A ZA 807467 A ZA807467 A ZA 807467A ZA 807467 B ZA807467 B ZA 807467B
Authority
ZA
South Africa
Prior art keywords
chemical compound
chemical
compound
Prior art date
Application number
ZA00807467A
Other languages
English (en)
Inventor
G Hodgson Jr
T Shumaker
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA807467B publication Critical patent/ZA807467B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA00807467A 1979-11-30 1980-11-28 Chemical compound ZA807467B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7941409 1979-11-30

Publications (1)

Publication Number Publication Date
ZA807467B true ZA807467B (en) 1982-07-28

Family

ID=10509524

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00807467A ZA807467B (en) 1979-11-30 1980-11-28 Chemical compound

Country Status (18)

Country Link
US (1) US4366158A (xx)
EP (1) EP0030023A3 (xx)
JP (1) JPS5699475A (xx)
KR (1) KR830004293A (xx)
AR (1) AR228442A1 (xx)
AT (1) AT375363B (xx)
AU (1) AU6495080A (xx)
CA (1) CA1156235A (xx)
DK (1) DK506480A (xx)
ES (1) ES497242A0 (xx)
FI (1) FI803704L (xx)
GB (1) GB2063868B (xx)
GR (1) GR71918B (xx)
HU (1) HU185224B (xx)
IL (1) IL61580A (xx)
IT (1) IT1221040B (xx)
NZ (1) NZ195688A (xx)
ZA (1) ZA807467B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06000795A (es) 2003-07-22 2006-08-23 Arena Pharm Inc Derivados de diaril y arilheteroaril urea como moduladores del receptor 5-ht2a de serotonina utiles para la profilaxis y tratamiento de desordenes relacionados con el mismo.
GB0507198D0 (en) * 2005-04-08 2005-05-18 Sb Pharmco Inc Process for preparing bicyclic compounds
GB0519758D0 (en) * 2005-09-28 2005-11-09 Glaxo Group Ltd Novel process
EP2508177A1 (en) 2007-12-12 2012-10-10 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
EP4119141A1 (en) 2015-06-12 2023-01-18 Axovant Sciences GmbH Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder
CA2992518A1 (en) 2015-07-15 2017-01-19 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143151A (en) * 1978-07-03 1979-03-06 The Dow Chemical Company Method for treating hyperglycemia in mammals using arylamino benzoic acids

Also Published As

Publication number Publication date
ES8203882A1 (es) 1982-04-01
IT8050277A0 (it) 1980-11-28
EP0030023A2 (en) 1981-06-10
GR71918B (xx) 1983-08-17
US4366158A (en) 1982-12-28
ES497242A0 (es) 1982-04-01
KR830004293A (ko) 1983-07-09
IL61580A0 (en) 1980-12-31
HU185224B (en) 1984-12-28
ATA582780A (de) 1983-12-15
IL61580A (en) 1984-06-29
IT1221040B (it) 1990-06-21
CA1156235A (en) 1983-11-01
JPS5699475A (en) 1981-08-10
AR228442A1 (es) 1983-03-15
AT375363B (de) 1984-07-25
AU6495080A (en) 1981-06-04
FI803704L (fi) 1981-05-31
GB2063868A (en) 1981-06-10
NZ195688A (en) 1984-09-28
GB2063868B (en) 1984-02-29
EP0030023A3 (en) 1981-09-02
DK506480A (da) 1981-05-31

Similar Documents

Publication Publication Date Title
GB2052478B (en) Guanidinothiazole compounds
ZA80796B (en) Chemical compounds
JPS5594363A (en) Phenoxyphenylpiperidine compound
JPS5610183A (en) 199hydroxyypgi compound
JPS5686134A (en) Eicosapentanoate compound
AU526976B2 (en) Chemical compounds
JPS55143971A (en) 144methoxymorphinann66one compound
JPS55124743A (en) 99aminoalkylfluorene compound
JPS56113779A (en) Compound
GB2125037B (en) 2-acetoxymethyl-penam compounds
ZA806146B (en) Heterocyclici compounds
JPS55136288A (en) Betaalactam contained compound
ZA807467B (en) Chemical compound
JPS5667369A (en) Phthaloperinone compound
JPS5594364A (en) Phenylthiophenylpiperidine compound
JPS5640675A (en) Chemical compound
JPS55113769A (en) 44substitutedd22iminoimidazolidine compound
GB2047708B (en) Butyloctyl-magnesium compounds
JPS55136264A (en) Pyridineacetoamide compound
IL61133A0 (en) 6-methylene-morphinan compounds
JPS56100858A (en) Halootriazinyl compound
JPS5632575A (en) Antiifreeze compound
ZA807948B (en) 2-oxybenzimidazoline compounds
GB2111983B (en) Cyclopent-4-en-5-olone compounds
DE3064156D1 (en) 1-halo-4-decene compounds